康弘药业
(002773)
| 流通市值：169.15亿 | | | 总市值：226.92亿 |
| 流通股本：6.87亿 | | | 总股本：9.21亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 6,273,956,852.19 | 6,435,444,571.76 | 3,828,071,098.77 | 3,333,562,707.08 |
| 交易性金融资产 | 440,000,000 | - | 2,565,000,000 | 2,665,000,000 |
| 应收票据及应收账款 | 203,838,994.03 | 189,097,202.93 | 166,926,034.06 | 202,377,526.21 |
| 其中：应收票据 | 1,200,000 | - | 185,556 | - |
| 应收账款 | 202,638,994.03 | 189,097,202.93 | 166,740,478.06 | 202,377,526.21 |
| 预付款项 | 63,322,685.33 | 12,722,163.96 | 42,378,031.18 | 30,927,896.99 |
| 其他应收款合计 | 8,894,421.72 | 4,407,216.13 | 8,977,573.81 | 6,654,385.43 |
| 存货 | 412,536,518.62 | 407,046,032.98 | 386,244,978.72 | 373,453,342.59 |
| 其他流动资产 | 36,774,124.95 | 35,743,387.12 | 25,556,663.74 | 20,294,805.79 |
| 流动资产合计 | 7,439,323,596.84 | 7,084,460,574.88 | 7,023,154,380.28 | 6,632,270,664.09 |
| 非流动资产: | | | | |
| 长期股权投资 | 15,579,582.85 | 15,794,362.62 | 15,972,341.33 | 16,210,901.5 |
| 固定资产 | 2,177,431,484.31 | 2,148,397,606.27 | 2,164,858,346.59 | 2,147,116,246.21 |
| 在建工程 | 34,108,974.26 | 97,561,580.51 | 88,146,621.31 | 126,263,204.57 |
| 生产性生物资产 | 3,563,717.61 | 3,868,770.06 | 3,744,554.3 | 4,037,401.82 |
| 使用权资产 | 3,086,027.92 | 3,531,441.19 | 3,974,665.97 | 4,433,234.91 |
| 无形资产 | 343,216,239.74 | 352,925,457.52 | 363,118,929.48 | 372,514,227.24 |
| 开发支出 | 78,687,513.37 | 60,665,923.49 | 35,575,773.41 | 27,662,493.9 |
| 长期待摊费用 | 950,955.1 | 1,089,988.01 | 1,704,570.08 | 5,162,561.29 |
| 递延所得税资产 | 97,775,247.41 | 128,853,449.18 | 136,306,995.94 | 175,877,901.87 |
| 其他非流动资产 | 15,797,978.66 | 22,715,590.94 | 33,476,680.93 | 21,188,202.92 |
| 非流动资产合计 | 2,770,197,721.23 | 2,835,404,169.79 | 2,846,879,479.34 | 2,900,466,376.23 |
| 资产总计 | 10,209,521,318.07 | 9,919,864,744.67 | 9,870,033,859.62 | 9,532,737,040.32 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 179,334,233.4 | 221,431,323.18 | 208,566,766.57 | 265,264,657.34 |
| 应付账款 | 179,334,233.4 | 221,431,323.18 | 208,566,766.57 | 265,264,657.34 |
| 预收款项 | 1,488,948.33 | 2,753,079.52 | 4,520,943.4 | 1,643,513.08 |
| 合同负债 | 16,527,058.41 | 2,061,455.33 | 5,362,728.33 | 17,188,658.77 |
| 应付职工薪酬 | 25,727,776.39 | 122,005,315.31 | 27,113,645.45 | 45,459,994.06 |
| 应交税费 | 78,755,411.35 | 54,763,454.72 | 65,386,297.46 | 49,211,715.26 |
| 其他应付款合计 | 139,474,440.45 | 46,206,559.73 | 303,509,611.25 | 226,670,718.38 |
| 一年内到期的非流动负债 | 1,290,930.8 | 1,684,628.13 | 1,474,126.12 | 1,655,221.95 |
| 其他流动负债 | 143,331,131.29 | 150,810,909.96 | 62,255,475.56 | 39,326,010.8 |
| 流动负债合计 | 585,929,930.42 | 601,716,725.88 | 678,189,594.14 | 646,420,489.64 |
| 非流动负债: | | | | |
| 租赁负债 | 911,583.56 | 1,822,568.74 | 2,202,961.89 | 2,070,655.55 |
| 长期应付款 | 4,816,077.75 | 5,384,296.52 | 8,198,518.85 | 6,376,029.21 |
| 递延收益 | 29,681,639.01 | 26,712,864.53 | 20,917,740.07 | 18,637,115.63 |
| 递延所得税负债 | 10,057,103.62 | 9,580,383.15 | 10,471,245.52 | 10,164,574.94 |
| 非流动负债合计 | 45,466,403.94 | 43,500,112.94 | 41,790,466.33 | 37,248,375.33 |
| 负债合计 | 631,396,334.36 | 645,216,838.82 | 719,980,060.47 | 683,668,864.97 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 921,320,954 | 921,320,954 | 921,320,954 | 921,299,954 |
| 资本公积 | 2,030,612,371.79 | 2,030,612,371.79 | 2,028,313,242.62 | 2,027,891,512.74 |
| 其他综合收益 | -1,180,292.83 | -1,454,006.96 | -1,650,044.48 | -1,392,577.3 |
| 盈余公积 | 515,315,206.97 | 515,315,206.97 | 515,315,206.97 | 515,315,206.97 |
| 未分配利润 | 6,140,604,094.78 | 5,833,121,960.34 | 5,703,061,659.89 | 5,399,854,228.83 |
| 归属于母公司股东权益合计 | 9,606,672,334.71 | 9,298,916,486.14 | 9,166,361,019 | 8,862,968,325.24 |
| 少数股东权益 | -28,547,351 | -24,268,580.29 | -16,307,219.85 | -13,900,149.89 |
| 股东权益合计 | 9,578,124,983.71 | 9,274,647,905.85 | 9,150,053,799.15 | 8,849,068,175.35 |
| 负债和股东权益合计 | 10,209,521,318.07 | 9,919,864,744.67 | 9,870,033,859.62 | 9,532,737,040.32 |
| 公告日期 | 2026-04-23 | 2026-04-23 | 2025-10-29 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |